Vaginismus
15
2
3
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
0.0%
0 terminated out of 15 trials
100.0%
+13.5% vs benchmark
13%
2 trials in Phase 3/4
57%
4 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (15)
Virtual Reality Exposure for Vaginismus: A Replicated Single-Case Design
Feasibility of Use of Vibrators With Vaginal Dilators for Vaginismus. (Vibrator Therapy and Dilators in Vaginismus)
VIBRating vs Traditional Therapy for Treatment of ENTry Dyspareunia
Prospective on Market Patient-reported Outcomes for Milli
Transperineal Ultrasound to Assess the Progress of Labour
Hydration and Acceptability of the Genital and Skin Mucosa of a Vaginal Moisturizer in Menopausal Women
Effect of Adding Interferential Current to Pelvic Floor Muscle Training on Vaginismus
Trial of SVTampons vs Glass Vaginal Dilators in Treatment of Vaginismus
Spinal Anesthesia Facilitated Sexual Intercourse As A Treatment Option For Vaginismus
Evaluation and Comparison of Women Pelvic Floor With and Without Sexual Dysfunction (Vaginismus)
Botox Injection for Treatment of Vaginismus
Injection of Botox in the Perineal Muscles in Resistant Cases of Vaginal Spasm
Childhood Sexual Abuse, Vaginismus and Labor Dystocia
Sexual Dysfunction and Dental Care
Botulinum Toxin Injection for Treatment of Vaginismus